- Home
- ANEB vs FCO Comparison
ANEB vs FCO Comparison
Compare ANEB & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANEB | FCO |
|---|---|---|
| Founded | 2020 | 1991 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 39.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANEB | FCO |
|---|---|---|
| Price | $1.09 | $3.04 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 138.8K | 100.1K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $4.73 |
| 52 Week High | $3.42 | $6.63 |
Technical Indicators
Market Signals| Indicator | ANEB | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 64.23 |
| Support Level | $1.02 | $2.89 |
| Resistance Level | $1.14 | $3.04 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 48.34 | 91.25 |
Price Performance
Historical ComparisonAbout ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.